Format

Send to

Choose Destination
Immunol Lett. 2018 Jan;193:42-50. doi: 10.1016/j.imlet.2017.11.007. Epub 2017 Nov 23.

Flagellin increases death receptor-mediated cell death in a RIP1-dependent manner.

Author information

1
Immunology Department, University Eötvös Lorand, H-1117 Budapest, Hungary.
2
Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
3
University Nice Sophia Antipolis, CNRS, Inserm, iBV, 06100 Nice, France.
4
Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; Sapientia Hungarian University of Transylvania, Department of Bioengineering, Romania.
5
Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; Sapientia Hungarian University of Transylvania, Department of Bioengineering, Romania. Electronic address: konczgb@gmail.com.

Abstract

Efficient adjuvants have the potential to trigger both innate and adaptive immune responses simultaneously. Flagellin is a unique pathogen-derived protein, which is recognized by pattern recognition receptors (PRRs) as well as by B-cell and T cell receptors thus providing an important link between innate and adaptive immunity. The aforementioned properties define flagellin as an optimal adjuvant. The induction of immunogenic cell death could be an additional expectation for adjuvants in the context of cancer immunotherapy due to their ability to activate dendritic cells (DC) to present tumor antigens through the engulfment of dying cells. The immunostimulatory potential of flagellin in the course of DC and lymphocyte activation is well documented, however the exact mechanism is not fully explored. Based on this limitation we sought to investigate the potential modulatory effects of flagellin on various cell death processes knowing that it plays detrimental roles in regulating the final outcome of various types of immune responses. Here we provide evidence that the pre-treatment of Jurkat T-cells with recombinant flagellin is able to increase the degree of cell death provoked by FasL or TNF-α, and concomitantly increases the cytotoxic potential of phytohemagglutinin activated T-lymphocytes in a TLR5 dependent way. In contrast to these flagellin-mediated effects on the death receptor-induced signaling events, the mitochondrial apoptotic pathway remained unaffected. Furthermore, the cell culture supernatant of wild type Salmonella enteritidis bacteria, but not their flagellin deficient variant, was able to enhance the Fas-induced cell death process. To define the molecular mechanisms of flagellin-mediated elevated levels of cell death we were able to detect the upregulation of RIP1-dependent signaling events. These findings demonstrate that the cooperative actions of pattern recognition and different death receptors are able to initiate the cell death process with the mobilization of RIP-dependent cell death modalities. This finding highlights the capability of flagellin to act as a potential adjuvant which is relevant for tumor immunotherapy.

KEYWORDS:

Adjuvant; Apoptosis; Necroptosis; PAMP; T cell; TLR

PMID:
29175315
DOI:
10.1016/j.imlet.2017.11.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center